Sector valuations Caplin Point Laboratories Limited NSE India S.E.
Stocks
CAPLIPOINT
INE475E01026
Pharmaceuticals
|
Market Closed -
NSE India S.E.
04:35:07 11/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2,754.90 INR | -1.45% |
|
-1.99% | +49.88% |
| 15/08 | Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026 | |
| 12/08 | Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 33.95x | 4.76x | 2.54x | 6.37x | 22.05x | 26.69x | 0.93% | 4.62TCr | |
| 16.25x | 1.81x | 8.99x | 2.01x | 8.92x | 11.32x | 1.63% | 3.88TCr | |
| 26.83x | 3.69x | -1.6x | 3.84x | 15.91x | 22.28x | 0.6% | 1.17TCr | |
| 26.59x | 2.94x | 3.79x | 3.22x | 16.68x | 21.4x | 0.95% | 1.16TCr | |
| 18.58x | 3.38x | 3.15x | 3.37x | 11.75x | 13.98x | 3.79% | 913.65Cr | |
| 9.22x | 1.52x | 1.33x | 2.13x | 5.5x | 6.69x | 4.82% | 730.05Cr | |
| 14.96x | 1.24x | 3.38x | 1.94x | 6.45x | 9.01x | 3.37% | 709.83Cr | |
| 29.42x | 5.4x | 0.42x | 3.85x | 17.9x | 21.58x | 0.16% | 714.6Cr | |
| 35.17x | 8.15x | 1.86x | 6.87x | 25.06x | 27.67x | 0.94% | 462.08Cr | |
| 15.95x | 0.78x | -0.03x | 2.2x | 9.4x | 11.89x | 1.69% | 432.27Cr | |
| 13.78x | 2.31x | 0.51x | 2.28x | 10.23x | 10.07x | 3.81% | 361.84Cr | |
| 16.41x | 2.91x | -9.78x | 3.32x | 12.52x | 14.94x | 2.97% | 286.72Cr | |
| 19.81x | 5.03x | 4.45x | 5.65x | 16.95x | 18.54x | 3.05% | 255.72Cr | |
| 13.3x | - | -0.87x | 9.35x | 9.18x | 9.46x | - | 236.07Cr | |
| 29.02x | - | -0.11x | - | - | - | - | 225.04Cr | |
| Average | 21.28x | 3.38x | 1.20x | 4.03x | 13.46x | 16.11x | 2.21% | 1.08TCr | |
| Weighted average by Cap. | 23.83x | 3.36x | 3.39x | 4.00x | 14.81x | 18.23x | 1.66% |
Select your edition
All financial news and data tailored to specific country editions
